Scan with a new PET dye to stage ovarian cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This pilot study uses a special PET/CT scan (with a radioactive tracer) to help doctors better “stage” high-grade epithelial ovarian cancer—especially when it’s advanced. The goal is to see whether the scan can improve planning for treatment like surgery or chemotherapy first.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older.
- You have (or doctors strongly suspect) high-grade epithelial ovarian cancer based on tests and scans.
- Your cancer is stage III or IV, and you are being considered for either surgery first (PCS) or chemotherapy first (NACT).
- You had a contrast CT scan of the abdomen and pelvis within the past 6 weeks, before the PET scan.
- You can consent and can safely complete the PET/CT scan (for example, not pregnant and able to lie still).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses two types of PET/CT scans (68Ga-FAPI-46 and 18F-FDG) to look for any returning ovarian cancer. The goal is to find recurrence early so you and your doctor can plan the next steps.
This trial tests a special PET/CT scan using a new tracer (68Ga-FAPI) to help show tumors in the pancreas, bile ducts, stomach, or certain ovarian cancers. It may help doctors better see where cancer is in preparation for surgery or biopsy.
This trial tests a new type of PET scan (Ga68-FAPI-46) to better see if cancer from the colon, rectum, or ovary has spread to the lining of the belly. If you are already scheduled for surgery to remove these cancer spots, this scan may help your doctors plan a more complete operation.
This early study tests a radioactive tracer (given as an injection) and tracks how it moves through the body using PET/CT scans. It may help doctors better understand how this tracer behaves in cancers of the ovaries, fallopian tubes, or the lining of the abdomen.
This trial tests a new PET/CT scan using a special tracer to detect cancer that has spread to the lining of the abdomen (peritoneal carcinomatosis) in people with colorectal, stomach, ovarian, or pancreatic cancer. It aims to see if this scan is better at finding the spread than standard imaging.
This early-phase study uses PET/CT scans to see how well a new radioactive tracer (a tiny dose of a special material) highlights solid tumors in the body. It may help researchers learn whether this tracer can better find and track tumor spots seen on standard scans.
Hear when a new High Grade Serous Ovarian Cancer (HGSOC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.